Lifevantage LFVN 深 沪
等待开盘 10-06 09:30:00 美东时间
9.48
-0.090
-0.94%
华盛通- 最 高9.8399
- 今 开9.57
- 成交量 8.60万股
- 最 低 9.44
- 昨 收 9.57
- 总市值 1.20亿
- 52周最高 27.25
- 市盈率 静 12.56
- 换手率 0.00%
- 52周最低 9.44
- 委 比 0.00%
- 总股本 1269.10万
- 历史最高 27.25
- 量 比 0.57
- 振 幅 4.18%
- 历史最低 0.49
- 每 手 1
- 风险率 3.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多LifeVantage Announces Closing of LoveBiome Acquisition
LifeVantage Corporation has completed the acquisition of LoveBiome, a direct sales company specializing in microbiome care, enhancing its presence in the gut and microbiome health market. The deal includes key assets and personnel, and aims to expand LifeVantage's product portfolio and reach in the US, Taiwan, and Europe. LifeVantage CEO Steve Fife highlighted the strategic growth opportunity, while LoveBiome CEO Kelly Olsen expressed excitement ...
10-02 12:00
LifeVantage to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
LifeVantage Corporation (Nasdaq: LFVN), a leader in health and wellness, announced that CEO Steve Fife and CFO Carl Aure will participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025. They will present at 11:00 a.m. Eastern Time, with a live webcast available on the company’s Investor Relations website. The presentation will also be archived for later access. LifeVantage, a pioneer in nutrigenomics, offers products d...
09-22 12:00
Lifevantage shares are trading lower after the company reported worse-than-expected Q4 sales results.
Lifevantage shares are trading lower after the company reported worse-than-expe...
09-05 23:58
Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Shares of Docusign Inc (NASDAQ:DOCU) rose sharply in pre-market trading after t...
09-05 17:20
Lifevantage Sees FY2026 Adj EPS $1.00-$1.15 vs $0.80 Est; Sees Sales $225.000M-$240.000M vs $230.300M Est
Lifevantage (NASDAQ:LFVN) is looking for FY2026 Adj EPS of $1.00-$1.15 vs $0.80 analyst estimate. sees sales of $225.000 million-$240.000 million vs $230.300 million analyst estimate.
09-05 04:07
Earnings Scheduled For September 4, 2025
Companies Reporting Before The Bell • Shoe Carnival (NASDAQ:SCVL) is projected ...
09-04 16:32
LifeVantage Acquires LoveBiome; Terms Not Disclosed
SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today
09-04 05:14
LifeVantage to acquire LoveBiome
LifeVantage Corporation (NASDAQ:LFVN) announced on Wednesday it has entered into a definitive agreement to acquire LoveBiome, a direct sales company dedicated to comprehensive microbiome care and well...
09-04 05:10
LifeVantage Announces Acquisition of LoveBiome, Expanding Leadership in Direct Sales, Microbiome Health and Wellness
LifeVantage Corporation has announced its acquisition of LoveBiome, a leader in microbiome care, to expand its network and strengthen its activation approach in the growing gut health market. LoveBiome's innovative P84 product aligns with LifeVantage's mission of promoting optimal health through activation. The deal, expected to close by mid-October, will integrate LoveBiome's expertise into LifeVantage's portfolio, enhancing its product offering...
09-03 21:00
LifeVantage to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
LifeVantage Corporation (NASDAQ: LFVN), a pioneer in nutrigenomics, announced that CEO Steve Fife and CFO Carl Aure will participate in the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025, in New York. They will meet with investors and present on September 10, 2025, at 1:00 p.m. Eastern Time. A live webcast of their presentation will be available on the Company’s Investor Relations website, with an archive availab...
09-02 20:05
